Clover Health Investments, CORP /DE 10-Q quarterly reports

Clover Health Investments, Corp. announced a substantial increase in total revenues and a significant swing to net income for the six months ended June 30, 2026, driven by membership growth and improved per-member premiums.

Clover Health Investments, Corp. announced a significant turnaround in its Q1 2026 financial performance, reporting a net income of $27.3 million compared to a net loss in the prior year.

Clover Health reported a significantly wider net loss in Q3 2025 despite revenue growth, alongside a critical downgrade of its primary Medicare Advantage PPO plans to 3.5 Stars for 2026.

Clover Health Investments, Corp. reported a net loss for Q2 2025, driven by a significant increase in medical claims incurred despite strong revenue and membership growth.

Clover Health's Q1 2025 results show revenue growth driven by increased membership in its Medicare Advantage plans.

Clover Health's Q3 2024 results show a decrease in net loss and improvements in key financial metrics, driven by growth in premiums and reduced operating expenses.

Clover Health's Q2 2024 results show a revenue increase but also highlight ongoing challenges with medical claims and restructuring costs.

Clover Health's first quarter of 2024 saw a revenue increase and a significant reduction in net losses, driven by growth in the insurance segment and strategic restructuring.